|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Metabolite or derivative |
| Approved drug? | Yes (source: FDA (1999)) |
IUPAC Name ![]() |
| (2E,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 7781 | alitretinoin |
Synonyms ![]() |
| 9-cis-retinoic acid |
| Panretin® |
| Toctino® |
Database Links ![]() |
|
| BindingDB Ligand | 31892 |
| CAS Registry No. | 5300-03-8 (source: Scifinder) |
| ChEBI | CHEBI:50648 |
| ChEMBL Ligand | CHEMBL705 |
| DrugBank Ligand | DB00523 |
| NURSA Ligand | 10.1621/M4CYJZD9LZ |
| PharmGKB Drug | PA164746900 |
| PubChem CID | 449171 |
| RCSB PDB Ligand | 9CR |
| Search Google for chemical match using the InChIKey | SHGAZHPCJJPHSC-ZVCIMWCZSA-N |
| Search Google for chemicals with the same backbone | SHGAZHPCJJPHSC |
| Search PubMed clinical trials | alitretinoin |
| Search PubMed titles | alitretinoin |
| Search PubMed titles/abstracts | alitretinoin |
| Wikipedia | Alitretinoin |
| Comments |
| Alitretinoin ia an important regulator of gene expression during normal growth and development, as well as in neoplasms. Alitretinoin is a retinoid receptor agonist. |